Skip to main content
Premium Trial:

Request an Annual Quote

FBI Approval Could Expand Market for Applied Biosystems Forensic DNA Kit


Life Technologies' Applied Biosystems unit said last week that its forensic DNA amplification kit has been approved for inclusion in the Federal Bureau of Investigation's National DNA Index System.

A spokesperson for Life Tech told PCR Insider this week that the approval constitutes an "endorsement" of the PCR-based kit by one of the most important legal entities in the US, and could lead to wider adoption of the technology in forensic laboratories around the country.

"Many forensic labs have used this technology previously, but now users can upload data [into NDIS]" and obtain leads in unsolved crimes on a national basis instead of on a local or regional basis, the spokesperson said.

In a statement, Life Tech's President of Human Identification Leonard Klevan added that "some laboratories have already generated valuable data from unsolved crimes and have been waiting for this opportunity to compare it to the NDIS database. Ultimately, this approval will help solve more crimes, reopen unsolved cold cases, exonerate the wrongly accused, and help identify missing persons."

The technology, called the AmpFlSTR MiniFiler PCR amplification kit, is a legacy product launched in 2007 from Applied Biosystems' applied markets division. MiniFiler is the world's first commercially available reagent kit designed with mini-short tandem repeat, or miniSTR, amplicons, which can increase the ability to obtain DNA results from compromised or degraded samples, Life Tech said.

The NDIS database is used by law enforcement professionals to compare genetic profile information from crimes committed across the US. It is managed by the FBI as the nation's forensic DNA database, and contains more than 7 million profiles and has produced more than 98,000 matches with DNA profiles, assisting in more than 97,000 criminal investigations.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.